CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside

The chimeric antigen receptor (CAR) is a genetically engineered receptor that combines a scFv domain, which specifically recognizes the tumor-specific antigen, with T cell activation domains. CAR-T cell therapies have demonstrated tremendous efficacy against hematologic malignancies in many clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Zhang, Zimu, Peng, Meiyu, Fu, Shuyu, Xue, Zhenyi, Zhang, Rongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214859/
https://www.ncbi.nlm.nih.gov/pubmed/28123893
http://dx.doi.org/10.1080/2162402X.2016.1251539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214859/
https://www.ncbi.nlm.nih.gov/pubmed/28123893
http://dx.doi.org/10.1080/2162402X.2016.1251539

Ejemplares similares